Milestone Pharmaceuticals Inc. - MIST
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Apr 20, 2026 | President and CEO | S | D | 36,500.0 | 2.26 | 82,490.0 | 446,244.0 | View | |
| Feb 05, 2026 | President and CEO | A | A | 679,000.0 | 0.0 | 0.0 | 679,000.0 | View | |
| Feb 05, 2026 | Chief Medical Officer | A | A | 204,000.0 | 0.0 | 0.0 | 204,000.0 | View | |
| Feb 05, 2026 | Chief Operating Officer | A | A | 204,000.0 | 0.0 | 0.0 | 204,000.0 | View | |
| Feb 05, 2026 | Chief Commercial Officer | A | A | 204,000.0 | 0.0 | 0.0 | 204,000.0 | View | |
| Feb 05, 2026 | CFO & EVP of Corp. Development | A | A | 204,000.0 | 0.0 | 0.0 | 204,000.0 | View | |
| Feb 04, 2026 | Chief Commercial Officer | A | A | 136,000.0 | 0.0 | 0.0 | 136,000.0 | View | |
| Feb 04, 2026 | Chief Commercial Officer | A | A | 204,000.0 | 0.0 | 0.0 | 204,000.0 | View | |
| Feb 04, 2026 | CFO & EVP of Corp. Development | A | A | 136,000.0 | 0.0 | 0.0 | 136,000.0 | View | |
| Feb 04, 2026 | CFO & EVP of Corp. Development | A | A | 204,000.0 | 0.0 | 0.0 | 204,000.0 | View | |
| Feb 04, 2026 | Chief Operating Officer | A | A | 136,000.0 | 0.0 | 0.0 | 136,000.0 | View | |
| Feb 04, 2026 | Chief Operating Officer | A | A | 204,000.0 | 0.0 | 0.0 | 204,000.0 | View | |
| Feb 04, 2026 | Chief Medical Officer | A | A | 136,000.0 | 0.0 | 0.0 | 136,000.0 | View | |
| Feb 04, 2026 | Chief Medical Officer | A | A | 204,000.0 | 0.0 | 0.0 | 204,000.0 | View | |
| Feb 04, 2026 | President and CEO | A | A | 453,000.0 | 0.0 | 0.0 | 453,000.0 | View | |
| Feb 04, 2026 | President and CEO | A | A | 679,000.0 | 0.0 | 0.0 | 679,000.0 | View | |
| Jan 28, 2026 | Chief Medical Officer | M | D | 20,100.0 | 0.0 | 0.0 | 60,300.0 | View | |
| Jan 28, 2026 | Chief Medical Officer | A | A | 100,000.0 | 0.0 | 0.0 | 100,000.0 | View | |
| Jan 28, 2026 | Chief Medical Officer | S | D | 12,245.0 | 1.93 | 23,632.85 | 113,181.0 | View | |
| Jan 28, 2026 | Chief Medical Officer | M | A | 20,100.0 | — | — | 125,426.0 | View | |
| Jan 28, 2026 | Chief Medical Officer | S | D | 58,007.0 | 2.32 | 134,576.24 | 105,326.0 | View | |
| Jan 28, 2026 | Chief Medical Officer | A | A | 100,000.0 | — | — | 163,333.0 | View | |
| Jan 28, 2026 | Chief Operating Officer | M | D | 20,100.0 | 0.0 | 0.0 | 60,300.0 | View | |
| Jan 28, 2026 | Chief Operating Officer | A | A | 100,000.0 | 0.0 | 0.0 | 100,000.0 | View | |
| Jan 28, 2026 | Chief Operating Officer | S | D | 12,245.0 | 1.93 | 23,632.85 | 49,848.0 | View | |
| Jan 28, 2026 | Chief Operating Officer | M | A | 20,100.0 | — | — | 62,093.0 | View | |
| Jan 28, 2026 | Chief Operating Officer | S | D | 58,007.0 | 2.32 | 134,576.24 | 41,993.0 | View | |
| Jan 28, 2026 | Chief Operating Officer | A | A | 100,000.0 | — | — | 100,000.0 | View | |
| Jan 28, 2026 | Chief Commercial Officer | M | D | 20,100.0 | 0.0 | 0.0 | 60,300.0 | View | |
| Jan 28, 2026 | Chief Commercial Officer | A | A | 100,000.0 | 0.0 | 0.0 | 100,000.0 | View | |
| Jan 28, 2026 | Chief Commercial Officer | S | D | 11,180.0 | 1.93 | 21,577.4 | 205,406.0 | View | |
| Jan 28, 2026 | Chief Commercial Officer | M | A | 20,100.0 | — | — | 216,586.0 | View | |
| Jan 28, 2026 | Chief Commercial Officer | S | D | 53,566.0 | 2.32 | 124,273.12 | 196,486.0 | View | |
| Jan 28, 2026 | Chief Commercial Officer | A | A | 100,000.0 | — | — | 250,052.0 | View | |
| Jan 28, 2026 | CFO & EVP of Corp. Development | M | D | 20,100.0 | 0.0 | 0.0 | 60,300.0 | View | |
| Jan 28, 2026 | CFO & EVP of Corp. Development | A | A | 100,000.0 | 0.0 | 0.0 | 100,000.0 | View | |
| Jan 28, 2026 | CFO & EVP of Corp. Development | S | D | 12,245.0 | 1.93 | 23,632.85 | 99,848.0 | View | |
| Jan 28, 2026 | CFO & EVP of Corp. Development | M | A | 20,100.0 | — | — | 112,093.0 | View | |
| Jan 28, 2026 | CFO & EVP of Corp. Development | S | D | 58,007.0 | 2.32 | 134,576.24 | 91,993.0 | View | |
| Jan 28, 2026 | CFO & EVP of Corp. Development | A | A | 100,000.0 | — | — | 150,000.0 | View | |
| Jan 28, 2026 | President and CEO | M | D | 66,600.0 | 0.0 | 0.0 | 199,800.0 | View | |
| Jan 28, 2026 | President and CEO | A | A | 280,000.0 | 0.0 | 0.0 | 280,000.0 | View | |
| Jan 28, 2026 | President and CEO | S | D | 34,523.0 | 1.93 | 66,629.39 | 482,744.0 | View | |
| Jan 28, 2026 | President and CEO | M | A | 66,600.0 | — | — | 517,267.0 | View | |
| Jan 28, 2026 | President and CEO | S | D | 133,054.0 | 2.32 | 308,685.28 | 450,667.0 | View | |
| Jan 28, 2026 | President and CEO | A | A | 280,000.0 | — | — | 583,721.0 | View | |
| Jan 09, 2026 | President and CEO | S | D | 43,000.0 | 2.25 | 96,750.0 | 303,721.0 | View | |
| Jan 09, 2026 | President and CEO | S | D | 500.0 | 2.25 | 1,125.0 | 346,721.0 | View | |
| Dec 11, 2025 | Chief Commercial Officer | G | D | 25,000.0 | 0.0 | 0.0 | 150,052.0 | View |